دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy
Zoher Ghogawala, MD1; Norma Terrin, PhD2; Melissa R. Dunbar, MPH1; Janis L. Breeze, MPH2; Karen M. Freund, MD, MPH2; Adam S. Kanter, MD3; Praveen V. Mummaneni, MD, MBA4; Erica F. Bisson, MD, MPH5; Fred G. Barker II, MD6; J. Sanford Schwartz, MD7,8; James S. Harrop, MD9; Subu N. Magge, MD1; Robert F. Heary, MD10; Michael G. Fehlings, MD, PhD11,12; Todd J. Albert, MD13,14; Paul M. Arnold, MD15; K. Daniel Riew, MD16; Michael P. Steinmetz, MD17; Marjorie C. Wang, MD, MPH18; Robert G. Whitmore, MD1; John G. Heller, MD19; Edward C. Benzel, MD17
doi : 10.1001/jama.2021.1233
JAMA. 2021;325(10):942-951
Importance Cervical spondylotic myelopathy is the most common cause of spinal cord dysfunction worldwide. It remains unknown whether a ventral or dorsal surgical approach provides the best results.
Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US
Donovan T. Maust, MD, MS1,2,3; Julie Strominger, MS2; H. Myra Kim, ScD2,3; Kenneth M. Langa, MD, PhD2,3,4,5; Julie P. W. Bynum, MD, MPH3,4; Chiang-Hua Chang, PhD3,4; Helen C. Kales, MD6; Kara Zivin, PhD1,2,3; Erica Solway, PhD, MSW, MPH3; Steven C. Marcus, PhD7
doi : 10.1001/jama.2021.1195
JAMA. 2021;325(10):952-961
Importance Community-dwelling older adults with dementia have a high prevalence of psychotropic and opioid use. In these patients, central nervous system (CNS)–active polypharmacy may increase the risk for impaired cognition, fall-related injury, and death.
Prevalence of SARS-CoV-2 in Karnataka, India
Manoj Mohanan, PhD1; Anup Malani, PhD2; Kaushik Krishnan, PhD3; Anu Acharya, MS4
doi : 10.1001/jama.2021.0332
JAMA. 2021;325(10):1001-1003
Association Between Changes in Social Distancing Policies in Ohio and Traffic Volume and Injuries, January Through July 2020
Li Li, MS1; Lucas M. Neuroth, MPH2; Edward Valachovic, PhD3; David C. Schwebel, PhD4; Motao Zhu, PhD2
doi : 10.1001/jama.2020.25770
JAMA. 2021;325(10):1003-1006
Screening for Lung Cancer
US Preventive Services Task Force
doi : 10.1001/jama.2021.1117
JAMA. 2021;325(10):962-970
Importance Lung cancer is the second most common cancer and the leading cause of cancer death in the US. In 2020, an estimated 228?820 persons were diagnosed with lung cancer, and 135?720 persons died of the disease. The most important risk factor for lung cancer is smoking. Increasing age is also a risk factor for lung cancer. Lung cancer has a generally poor prognosis, with an overall 5-year survival rate of 20.5%. However, early-stage lung cancer has a better prognosis and is more amenable to treatment.
Broadened Eligibility for Lung Cancer Screening
Louise M. Henderson, PhD1,2; M. Patricia Rivera, MD1,3; Ethan Basch, MD1,3,4
doi : 10.1001/jama.2020.26422
JAMA. 2021;325(10):939-941
Screening for Lung Cancer With Low-Dose Computed Tomography
Daniel E. Jonas, MD, MPH1,2; Daniel S. Reuland, MD, MPH3,4,5; Shivani M. Reddy, MD, MSc1,6; Max Nagle, MD, MPH7; Stephen D. Clark, MD, MPH8; Rachel Palmieri Weber, PhD1,4; Chineme Enyioha, MD, MPH9; Teri L. Malo, PhD, MPH5; Alison T. Brenner, PhD, MPH5; Charli Armstrong, BA1,4; Manny Coker-Schwimmer, MPH1,4; Jennifer Cook Middleton, PhD1,4; Christiane Voisin, MSLS1,4; Russell P. Harris, MD, MPH3,4
doi : 10.1001/jama.2021.0377
JAMA. 2021;325(10):971-987
Importance Lung cancer is the leading cause of cancer-related death in the US.
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography
Rafael Meza, PhD1; Jihyoun Jeon, PhD1; Iakovos Toumazis, PhD2,3; Kevin ten Haaf, PhD4; Pianpian Cao, MPH1; Mehrad Bastani, PhD2,3; Summer S. Han, PhD5; Erik F. Blom, MD, PhD4; Daniel E. Jonas, MD, MPH6,7; Eric J. Feuer, PhD8; Sylvia K. Plevritis, PhD2; Harry J. de Koning, MD, PhD4; Chung Yin Kong, PhD9,10
doi : 10.1001/jama.2021.1077
JAMA. 2021;325(10):988-997
Importance The US Preventive Services Task Force (USPSTF) is updating its 2013 lung cancer screening guidelines, which recommend annual screening for adults aged 55 through 80 years who have a smoking history of at least 30 pack-years and currently smoke or have quit within the past 15 years.
Addressing Consolidation in Health Care Markets
Leemore Dafny, PhD1
doi : 10.1001/jama.2021.0038
JAMA. 2021;325(10):927-928
Overcoming the Market Dominance of Hospitals
Robert P. Kocher, MD1; Soleil Shah, MSc1; Amol S. Navathe, MD, PhD2,3
doi : 10.1001/jama.2021.0079
JAMA. 2021;325(10):929-930
Rapid Implementation of a Vaccination Superstation
Christopher A. Longhurst, MD, MS1,2; Brendan Kremer, MHA1; Patricia S. Maysent, MBA, MHA1
doi : 10.1001/jama.2021.0801
JAMA. 2021;325(10):931-932
The Centers for Medicare & Medicaid Services Requirement for Shared Decision-making for Lung Cancer Screening
Richard M. Hoffman, MD, MPH1,2; Daniel S. Reuland, MD, MPH3,4; Robert J. Volk, PhD5
doi : 10.1001/jama.2021.1817
JAMA. 2021;325(10):933-934
The Triple Aim Applied to Correctional Health Systems
Donald M. Berwick, MD, MPP1,2; Adam L. Beckman, BS2; Suhas Gondi, BA2
doi : 10.1001/jama.2021.0263
JAMA. 2021;325(10):935-936
Trauma Comes Home
Melissa Red Hoffman, MD, ND1
doi : 10.1001/jama.2021.0594
JAMA. 2021;325(10):937-938
Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2
John T. Brooks, MD1; Jay C. Butler, MD1
doi : 10.1001/jama.2021.1505
JAMA. 2021;325(10):998-999
The Price of Success—How to Evaluate COVID-19 Vaccines When They’re Available Outside of Clinical Trials
Rita Rubin, MA
doi : 10.1001/jama.2021.0641
JAMA. 2021;325(10):918-921
Building Health Care Better Means Reining In Costs
David Cutler, PhD1
doi : 10.1001/jama.2021.1578
JAMA. 2021;325(10):922-923
More Resources, Community Outreach Needed to Boost Contact Tracing
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.1575
JAMA. 2021;325(10):925
Dramatic Cervical Cancer Screening Decline During Pandemic
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.1977
JAMA. 2021;325(10):925
Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient
Jennifer Abbasi
doi : 10.1001/jama.2021.2493
JAMA. 2021;325(10):924
Saliva Tests Comparable With Nasal Swabs for SARS-CoV-2 Detection
Jennifer Abbasi
doi : 10.1001/jama.2021.1780
JAMA. 2021;325(10):924
COVID-19 “Liquid Biopsy” Could Offer Monitoring, Prognostic Tool
Jennifer Abbasi
doi : 10.1001/jama.2021.2496
JAMA. 2021;325(10):924
Addiction Screening—The A Star Is Born Movie Series and Destigmatization of Substance Use Disorders
Benjamin J. Oldfield, MD, MHS1,2; Jeanette M. Tetrault, MD2; Gretchen Berland, MD2
doi : 10.1001/jama.2020.25256
JAMA. 2021;325(10):915-917
Monoclonal Antibodies for COVID-19
Elizabeth C. Lloyd, MD1; Tejal N. Gandhi, MD1; Lindsay A. Petty, MD1
doi : 10.1001/jama.2021.1225
JAMA. 2021;325(10):1015
Use of e-Cigarettes for Smoking Cessation
Michael J. Lanspa, MD1; Denitza P. Blagev, MD1; Sean J. Callahan, MD2
doi : 10.1001/jama.2020.27207
JAMA. 2021;325(10):1006
Use of e-Cigarettes for Smoking Cessation—Reply
Mark J. Eisenberg, MD, MPH1; Andréa Hébert-Losier, MSc2; Kristian B. Filion, PhD3
doi : 10.1001/jama.2020.27210
JAMA. 2021;325(10):1006-1007
Effect of Emergency Department Care Bundle on Elderly Patients With Acute Heart Failure
Kan Liu, MD, PhD1
doi : 10.1001/jama.2020.27291
JAMA. 2021;325(10):1007.
Effect of Emergency Department Care Bundle on Elderly Patients With Acute Heart Failure—Reply
Yonathan Freund, MD, PhD1; Judith Gorlicki, MD2
doi : 10.1001/jama.2020.27294
JAMA. 2021;325(10):1007-1008
